FDA approves pre-surgical breast cancer drug

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WASHINGTON, D.C. – Pull out your pink ribbons! Heck, rock all the pink you want. It’s Breast Cancer Awareness Month, and the occasion is met with encouraging news.

The U.S. Food and Drug Administration approved the first ever pre-surgical breast cancer drug.

It’s called Perjeta and will be an option for women diagnosed in the early stages who have a high risk of having their cancer spread.

The hope is the drug will shrink tumors, making them easier to remove in surgery. For some women, this would prevent a full mastectomy.

While there’s no way to prevent cancer, let October be a reminder: Early detection is the key to survival.